Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Mar 25.
Published in final edited form as: Bioconjug Chem. 2022 Nov 6;33(11):2189–2196. doi: 10.1021/acs.bioconjchem.2c00419

Rapid Electrophilic Cysteine Arylation with Pyridinium Salts

Bradley M Lipka 1, Vincent M Betti 2, Daniel S Honeycutt 3, Daniel L Zelmanovich 4, Max Adamczyk 5, Ruojun Wu 6, Harrison S Blume 7, Caitlin A Mendina 8, Jacob M Goldberg 9, Fang Wang 10
PMCID: PMC13011920  NIHMSID: NIHMS2155952  PMID: 36335596

Abstract

Here, we present a series of fluorinated cationic reagents that enable rapid arylation of cysteine under mild conditions compatible with proteins and peptides. The highly polarized C–F bond and attractive nucleophile–electrophile Coulombic interactions substantially accelerate cysteine arylation, leading to unusually high rate constants on the order of 100 M−1·s−1 and allowing for equimolar labeling of substrates at micromolar concentrations. The synthetic modularity of this approach promotes the direct coupling of structurally diverse phenol-containing functional motifs to cysteine residues of biomacromolecules with high efficiency. This user-friendly chemistry enables fast bond formation between commonly used bioconjugation partners, thus greatly streamlining the synthetic chemistry workflow, and can be easily developed as convenient kits for chemical biology and medicinal chemistry applications.

Graphical Abstract

graphic file with name nihms-2155952-f0001.jpg

INTRODUCTION

Small molecule-based bioconjugation enables in vitro and in vivo functionalization of proteins and peptides, significantly expanding the chemical space of biomacromolecules.14 Among these transformations, nucleophilic aromatic substitution (SNAr) of cysteine residues is a widely employed strategy for protein bioconjugation.57

The rational design of reagents for selective nucleophilic cysteine arylation generally follows the current mechanistic understanding of SNAr reactions. In the classical view,810 SNAr reactions proceed through a stepwise addition-elimination mechanism. When the addition step is rate-limiting, SNAr reactions are usually accelerated if the aromatic electrophile bears an electron-withdrawing group (EWG) as the activator and a small, electronegative substituent as the leaving group (LG).9,11 The EWG stabilizes the transition state (TS) of the addition step when the reactants approach each other. The barrier to this event is further lowered if the Cipso–LG bond is polarized by a strongly electronegative LG, such as a halide, and the incoming nucleophile experiences reduced repulsive interactions with a small LG.11,12 In line with this canonical mechanism, a variety of aromatic compounds, functionalized with both strong EWGs and favorable LGs, including fluoride, chloride, and sulfinate, have been identified as versatile labeling agents for nucleophilic cysteine arylation and have been used to great advantage in many biochemical studies (Figure 1A).1318

Figure 1.

Figure 1.

(A) Conventional SNAr electrophiles for cysteine labeling. (B) Rapid cysteine labeling using N-alkyl-o-fluoropyridinium salts.

Although these reagents facilitate cysteine arylation, they are disadvantageous in two crucial aspects—limited synthetic modularity and undesired hydrophobicity. First, conventional labeling reagents are frequently activated by multiple EWGs on a single aromatic ring, leaving few synthetic handles to derivatize the reagents for advanced applications. Second, these labeling reagents are generally hydrophobic in nature and scarcely soluble in water, thus necessitating the use of organic cosolvents incompatible with certain biomolecules.5 In addition, although the incorporation of hydrophobic tags, such as polyfluorinated arenes,19 can potentially improve the pharmacokinetics of the resulting conjugate,20 in other instances, it is desirable to label proteins with hydrophilic moieties that do not significantly perturb native structure and possibly preserve wild-type protein–protein interactions.21 Overall, these challenges highlight the current limitations of cysteine arylation chemistry and reflect the increasing need for rapid, hydrophilic tools allowing for bioconjugation at low micromolar concentrations within hours.2224

RESULTS AND DISCUSSION

Here, we devised a novel strategy for rapid cysteine arylation using pyridinium salts (CAP, Figure 1B). We hypothesized that N-alkylation of ortho-fluoropyridines would convert rather inert, hydrophobic pyridines into highly reactive, hydrophilic electrophiles, as described below.

First, because they are ionic compounds, N-alkylated fluoropyridinium salts should exhibit significantly improved water solubility relative to typical neutral arylating agents, such as perfluoroarenes and 4-chloro-7-nitrobenzofurazan. Furthermore, despite the fact that monohalogenation of aromatic compounds often significantly increases hydrophobicity, such effects are minimal with fluorine,25,26 rendering fluoropyridinium salts the most water-soluble among all halopyridinium analogues. Second, N-alkylated pyridinium motifs are substantially electron-withdrawing, as indicated by the high Hammett σ values of N-methyl-m-pyridinium (σ = 2.10) and N-methyl-p-pyridinium (σ = 2.57) substituents.27 In comparison, the nitro group, although widely employed as a strong activating group for SNAr electrophiles, has much lower substituent constants of σm = 0.71 and σp = 0.78.28 In addition, both natural bond orbital (NBO) analysis29 and electrostatic potential calculations indicate the highly positively charged ipso carbon of N-methyl-o-fluoropyridinium (Table 1). These results also suggest that the o-fluoropyridinium ion can serve as a viable electrophile in SNAr reactions. Empirically, the exceptional electron-withdrawing capacity of pyridinium motifs corresponds to the high reactivity of halogenated pyridinium salts, as exemplified by the rapid reaction between N-methyl-o-fluoropyridinium iodide (CAP1) and the hydroxide anion.30 According to Mayr’s reactivity scale,31,32 the cysteine thiolate is about 10 orders of magnitude more nucleophilic than hydroxide in aqueous media.33,34 Based on these considerations, we anticipated that the o-fluoropyr-idinium-cysteine reaction pair would exhibit fast chemical kinetics suitable for bioconjugation, even at low substrate concentrations.35,36 We calculated the activation barrier of the reaction between N-acetylcysteine amide and a series of electrophiles in water (Table 1). The results showed a dramatic reduction in TS energy when the o-fluoropyridinium cation is used as the electrophile, which further validates our proposal. Compared to the chlorinated counterpart, the o-fluoropyridinium cation exhibits about 100-fold higher reactivity, highlighting the special ability of the polarized C–F bond to promote SNAr reactions.37 Alternatively, the p- and o-cyano-N-methylpyridinium cations exhibit 30 to 50-fold higher reactivity toward piperidine in methanol, respectively, compared to the o-fluoropyridinium moiety.38 Despite the promise of these electrophilic scaffolds for cysteine bioconjugation, the o-fluoropyridinium cation is a safer reagent that does not generate unwanted cyanide byproduct. Finally, the prominent electron-withdrawing ability of pyridinium motifs facilitates the effective activation of SNAr electrophiles without introducing multiple EWGs, thus providing multiple synthetic handles on the aromatic ring. Such extraordinary synthetic modularity of the CAP reagents enables one-pot conjugation of a large collection of functional small molecules to proteins and peptides for rapid, operationally easy structural diversification of biomacromolecules.

Table 1.

Comparison of Properties of Different SNAr Electrophiles

electrophile ESP[a] natural atomic charge of ipso carbon[b] ΔGSNAr with N-acetylcysteine amide (kcal/mol)[c]
graphic file with name nihms-2155952-t0002.jpg graphic file with name nihms-2155952-t0003.jpg +0.57 +26.9
graphic file with name nihms-2155952-t0004.jpg graphic file with name nihms-2155952-t0005.jpg +0.65 +8.4
graphic file with name nihms-2155952-t0006.jpg graphic file with name nihms-2155952-t0007.jpg +0.28 +22.7
graphic file with name nihms-2155952-t0008.jpg graphic file with name nihms-2155952-t0009.jpg +0.20 +10.5
a

The electrostatic potential (ESP) plotted on an isodensity surface of the electron density set to 0.01 e/bohr3. Red = −33 kcal/mol, blue = +100 kcal/mol.

b

Natural atomic charge.

c

Gibbs free energy of activation of the rate-determining step of the reaction with N-acetylcysteine amide calculated at CPCM-M06/def2-TZVP in water.

To test this hypothesis, we quantified the electrophilic reactivity of N-methyl-o-fluoropyridinium iodide (CAP1), the prototypical CAP electrophile, toward a series of common biological nucleophiles. As shown in Figure 2A, eq 1, CAP1 rapidly reacted with glutathione (GSH) at 25 °C in pH 7.0 PIPES buffer with a second-order rate constant of 1.16 × 102 M−1·s−1. The rate constants of the reaction between CAP1 and other cysteine derivatives are analogous (Figures S42, S43, S54, and S55). Such rapid reactions are highly desirable for stoichiometric bioconjugation at micromolar concentrations.35,36 In pH 6.0 PIPES buffer, the rate constant decreased by 90% to 1.22 × 101 M−1·s−1 (Figure S39). This observation is consistent with the 10-fold reduction in free thiolate, which is the ultimate nucleophile of this reaction.39 To address the need for conducting arylation under low-salt conditions, we tested the reaction in water. Although in unbuffered aqueous media, we observed a lower reaction rate, presumably due to the significantly lower availability of the requisite thiolate nucleophile, these conditions are still effective for labeling substrates when the concentrations of both reactants are in the millimolar range (Figure 2A, eq 1, Figures S41 and S61). In contrast to the high reactivity of fluorine-containing CAP1, N-methyl-o-chloropyridinium iodide, known as Mukaiyama reagent,40 was 100-fold less reactive, indicating the essential role of the polarized C–F bond in activating SNAr reactions (Figure 2A, eq 2 and Figure S45).37 This observation may be explained by density functional theory (DFT) calculations at the CPCM(water)-M062X/def2-TZVP level, which showed that the barrier to the reaction of GSH with CAP1 was about 2 kcal/mol lower than that with Mukaiyama reagent via the classical ionic nonvicarious SNAr pathway (Figures S66 and S67).4143

Figure 2.

Figure 2.

(A) Reaction kinetics of o-halopyridinium salts with various nucleophiles under different conditions. (B) Preparative scale labeling of 400 μM GSH with equimolar CAP1 in pH 7.0 PIPES buffer. High-performance liquid chromatography (HPLC) of the reaction mixture shows quantitative reaction yield and remarkable selectivity.

The practicality and efficiency of this labeling strategy not only depend on the rate constant of the desired cysteine arylation but also on the side reactions between CAP1 and other nucleophiles. To quantify the aqueous stability of CAP1, we determined the hydrolysis rate constant of CAP1. As shown in Figure 2A, eq 3, hydrolysis of CAP1 was slow in both water (Figure S49) and pH 7.0 PIPES buffer (Figure S50) at 25 °C, corresponding to half-lives of 12 h and 45 min, respectively. Because CAP1 is persistent in water, its aqueous solutions can be routinely handled at ambient temperatures and stored at −20 °C for 2 weeks without significant degradation. Despite the faster hydrolysis in PIPES buffer, this side reaction is substantially slower than the desired substitution and can be mitigated using a slight excess of CAP1 when cysteine is used at low micromolar concentrations. We also tested the reaction of CAP1 with other common biological nucleophiles, including phenolic, amino, and carboxylic groups, all of which exhibited reactivity at least 200-fold lower than that with cysteine (Figure 2A, eq 4, Figures S46 and S58S60). The differential reactivities toward CAP1 follow the general trend revealed by Mayr’s quantitative nucleophilicity scale33,34,44 and permit rapid, selective cysteine arylation under fully biocompatible conditions. To demonstrate the high efficiency of CAP1 labeling, we reacted 400 μM GSH with equimolar CAP1 for 1 h in pH 7.0 PIPES buffer at 25 °C (Figure 2B). The HPLC chromatogram of this reaction mixture showed the quantitative generation of a highly pure GSH-CAP1 adduct, the structure of which was confirmed by tandem mass spectrometry (Figure S1) and NMR spectroscopy (Figures S138S146). The stability of the arylation products affects the potential scope of cysteine labeling applications. To evaluate the reversibility of cysteine arylation, we treated N-acetyl-L-cysteine methyl ester-CAP1 adduct (11.1 mM) with 3.0 equiv of GSH in D2O at 25 °C and found a half-life of more than 300 h under these conditions, thus demonstrating the suitability of CAP-based cysteine arylation for various experimental objectives (Figure S63 and similar results in Figure S64).

We next used CAP labels to arylate a panel of cysteine-containing biomolecules. To test the chemoselectivity of CAP1 for structurally complicated peptides, we chose to label the cysteine residues of reduced oxytocin, a nonapeptide hormone bearing a tyrosine and an unprotected N-terminus (Scheme 1A). In the presence of tris(2-carboxyethyl)phosphine (TCEP), a widely used reagent for reducing disulfide bonds, oxytocin was rapidly functionalized by CAP1 under mild conditions. Tandem mass spectrometry confirmed the exclusive labeling of the cysteine residues, a result consistent with our understanding of the kinetic parameters (Figure S3). One advantage of CAP labels is synthetic versatility, which allows for the easy incorporation of various functional motifs commonly employed in chemical biology. To this end, we developed CAP1-derived labels functionalized with an azido group (CAP1-N3) or a terminal alkyne (CAP1-CCH), respectively (Scheme 1B,C and Figures S4 and S5). Both CAP1-N3 and CAP1-CCH were easily synthesized in quantitative yields by ethylating the corresponding o-fluoropyridine derivatives using Meerwein’s salts45,46 and exhibited reactivity similar to that of the parent CAP1.

Scheme 1.

Scheme 1.

Equation 1: Preparative Scale Arylation of Cysteine Residues of Reduced Oxytocin with CAP1; Equation 2: Preparative Scale Arylation of GSH with CAP1-N3; Equation 3: Preparative Scale Arylation of GSH with CAP1-CCH

An ideal bioconjugation strategy should facilitate the straightforward attachment of structurally diverse functional cargo to biomacromolecules—a feature usually absent in existing electrophilic cysteine arylation methods. We considered the use of CAP1 derivatives that possess two electrophilic reactive sites as modular linkers for connecting complicated molecular scaffolds to cysteine residues via two sequential nucleophilic substitution reactions. Accordingly, we prepared the highly electrophilic o,o′-difluoro-N-methylpyridinium tetrafluoroborate (CAP1-F) as an effective bioconjugation partner for relatively weak nucleophiles, such as phenols. The additional ortho fluorine substituent of CAP1-F led to a 30-fold increase in reactivity (Figure S47), thus facilitating rapid reaction with phenols at low millimolar concentrations under mild conditions (Figure 3A). In contrast, the electrophilicity of the resulting CAP1-OPh was 100 times lower than that of CAP1-F (Figures 3A and S48). Such a substantial difference in reactivity was crucial for generating the labeling intermediate CAP1-OPh from CAP1-F in nearly quantitative yield while minimizing the formation of the undesired diphenolated adduct. The CAP1-OPh species, on the other hand, exhibited electrophilicity similar to that of CAP1 and rapidly arylated cysteine at low concentrations (Figures 3A and S48). Advantageously, the half-life of CAP1-F in pH 7.0 PIPES buffer at 25 °C is approximately 3 min. As such, any excess CAP1-F that does not react with the phenol rapidly decomposes to 6-fluoro-N-methylpyridone, which is inert toward cysteine, thus preventing unwanted cysteine-CAP1-F reactions. Figure 3BD depicts the use of CAP1-F to ligate a series of functional phenol derivatives to cysteine residues in a one-pot, two-step fashion.

Figure 3.

Figure 3.

One-pot two-step ligation of phenol-containing molecules to cysteines using CAP1-F reagent. (A) General protocol for one-pot two-step electrophilic cysteine arylation and representative kinetic data. (B) Preparative scale conjugation of phenol to the cysteine residue of GSH. (C) Preparative scale conjugation of a TAMRA-phenol derivative to the cysteine residue of GSH. (D) Preparative scale conjugation of a biotin-phenol derivative to the cysteine residue of GSH.

As demonstrated by the reaction sequence employing phenol and GSH, this CAP1-F-based approach afforded the desired conjugate, GSH-CAP1-OPh, quantitatively, as determined by analytical HPLC (Figure 3B, red trace, Figure S6). The phenol substitution also occurred smoothly in organic solvents in the presence of bases and is suitable for incorporating substrates with low aqueous solubility (Figure 3B, green and blue traces). The CAP1-F reagent also enabled efficient conjugation of complicated structural motifs, including TAMRA- and biotin-phenol derivatives, to GSH, demonstrating the excellent modularity and synthetic versatility of the method (Figures 3C,D, S7, and S8).

We next investigated the application of CAP reagents for the arylation of proteins. Our initial efforts focused on the arylation of the catalytic Cys-25 of papain, a 23.4 kDa protease, using CAP1 in pH 4.5 acetate buffer at room temperature (Scheme 2A). The reaction went smoothly, as evidenced by a functional assay revealing substantial inhibition of proteolytic activity (Figure S9). To explore the functionalization of larger proteins using CAP labels, we chose the 66.5-kDa bovine serum albumin (BSA) as a model substrate, which reacted with CAP1 rapidly (Scheme 2B, Figures S10S14). Additionally, we found that the alkyne-containing CAP1-CCH arylated the Cys-58 residue of BSA within 1 h under biocompatible conditions. The resulting functionalized BSA-CAP1-CCH was well-suited for routine copper-catalyzed azide-alkyne cyclization4750 with 7-azido-4-methylcoumarin, exhibiting the versatility of CAP reagents (Scheme 2C and Figures S16S20). We also employed the modular CAP1-F building block to install complicated molecular motifs to a protein in a one-pot two-step fashion. Scheme 2D depicts the fluorescent labeling of GFP V150C using an in situ-generated CAP1-TAMRA synthetic intermediate, which enabled fast, convenient cysteine arylation of GFP V150C in pH 7.0 PIPES buffer at room temperature (Scheme 2D and Figure S21). Taken together, these experiments reflect the modularity and efficiency of the CAP labeling strategy for the direct coupling of complicated molecules to proteins and peptides.

Scheme 2.

Scheme 2.

(A) Labeling Papain with CAP1; (B) Labeling BSA with CAP1; (C) Labeling BSA with CAP1-CCH and the Subsequent Incorporation of Coumarin via Copper-Catalyzed Azide-Alkyne Cyclization; (D) Modular Synthesis of CAP1-TAMRA for Labeling GFP V150C

CONCLUSIONS

We developed a highly modular synthetic method for rapid electrophilic cysteine arylation using N-alkyl-o-fluoropyridinium salts (CAP). This particularly fast reaction was facilitated by both the electron-deficient nature of the cationic ortho-pyridinium construct and the unique chemical properties of the carbon–fluorine bond. The prototypical labeling reagent, CAP1, exhibited reactivity toward cysteine, with a rate constant of about 100 M−1·s−1 under fully biocompatible conditions and enabled rapid, nearly quantitative cysteine ligation at low micromolar concentrations. Synthetically, the CAP strategy is highly versatile. The pyridinium scaffold can easily accommodate various functionalities and synthetic handles useful for chemical biology without significant loss in its high reactivity. The extraordinary modularity of the CAP labeling, exemplified by o,o′-difluoro-N-methylpyridinium tetrafluoroborate (CAP1-F), allowed for directly coupling phenol derivatives to cysteines in a one-pot, two-step fashion. Overall, we anticipate this chemistry to be a practical, user-friendly addition to the chemical biology toolbox.

Supplementary Material

Supporting Information

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.bioconjchem.2c00419.

Supplementary figures and schemes, materials, experimental procedures; characterization data (1D and 2D NMR, LCMS, HRMS) for all small molecule compounds; HRMS, MS/MS, and MALDI for peptides and proteins; reaction kinetics; in situ NMR spectra for product stability studies; and DFT calculations (PDF)

ACKNOWLEDGMENTS

This research was made possible by the use of equipment available through the Rhode Island Institutional Development Award (IDeA) Network of Biomedical Research Excellence from the National Institute of General Medical Sciences of the National Institutes of Health under Grant Number P20GM103430 through the Centralized Research Core facility. High-Performance Computing at the University of Rhode Island is gratefully acknowledged. This material is based upon work supported by the National Science Foundation under Grant No. CHE-2117141.

Footnotes

Complete contact information is available at: https://pubs.acs.org/10.1021/acs.bioconjchem.2c00419

The authors declare the following competing financial interest(s): A provisional patent application has been submitted by the University of Rhode Island and Colgate University to cover this work.

Contributor Information

Bradley M. Lipka, Department of Chemistry, University of Rhode Island, Kingston, Rhode Island 02881, United States

Vincent M. Betti, Department of Chemistry, Colgate University, Hamilton, New York 13346, United States

Daniel S. Honeycutt, Department of Chemistry, University of Rhode Island, Kingston, Rhode Island 02881, United States

Daniel L. Zelmanovich, Department of Chemistry, Colgate University, Hamilton, New York 13346, United States

Max Adamczyk, Department of Chemistry, University of Rhode Island, Kingston, Rhode Island 02881, United States.

Ruojun Wu, Department of Chemistry, Colgate University, Hamilton, New York 13346, United States.

Harrison S. Blume, Department of Chemistry, Colgate University, Hamilton, New York 13346, United States

Caitlin A. Mendina, Department of Chemistry, Colgate University, Hamilton, New York 13346, United States

Jacob M. Goldberg, Department of Chemistry, Colgate University, Hamilton, New York 13346, United States

Fang Wang, Department of Chemistry, University of Rhode Island, Kingston, Rhode Island 02881, United States.

REFERENCES

  • (1).Hermanson GT Bioconjugate Techniques, 3rd ed.; Academic Press: Boston, 2013. [Google Scholar]
  • (2).Chalker JM; Bernardes GJL; Davis BGA “Tag-and-Modify” Approach to Site-Selective Protein Modification. Acc. Chem. Res 2011, 44, 730–741. [DOI] [PubMed] [Google Scholar]
  • (3).Hoyt EA; Cal PMSD; Oliveira BL; Bernardes GJL Contemporary Approaches to Site-Selective Protein Modification. Nat. Rev. Chem 2019, 3, 147–171. [Google Scholar]
  • (4).Jun JV; Chenoweth DM; Petersson EJ Rational Design of Small Molecule Fluorescent Probes for Biological Applications. Org. Biomol. Chem 2020, 18, 5747–5763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (5).Zhang C; Vinogradova EV; Spokoyny AM; Buchwald SL; Pentelute BL Arylation Chemistry for Bioconjugation. Angew. Chem., Int. Ed 2019, 58, 4810–4839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (6).Chalker JM; Bernardes GJL; Lin YA; Davis BG Chemical Modification of Proteins at Cysteine: Opportunities in Chemistry and Biology. Chem. Asian J 2009, 4, 630–640. [DOI] [PubMed] [Google Scholar]
  • (7).Gunnoo SB; Madder A Chemical Protein Modification through Cysteine. ChemBioChem 2016, 17, 529–553. [DOI] [PubMed] [Google Scholar]
  • (8).Rohrbach S; Smith AJ; Pang JH; Poole DL; Tuttle T; Chiba S; Murphy JA Concerted Nucleophilic Aromatic Substitution Reactions. Angew. Chem., Int. Ed 2019, 58, 16368–16388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (9).Terrier F Modern Nucleophilic Aromatic Substitution; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2013; p 409. [Google Scholar]
  • (10).Olah GA; Mayr H Carbanions. II. Carbon-13 Nuclear Magnetic Resonance Study of Meisenheimer Complexes and Their Charge Distribution Pattern. J. Org. Chem 1976, 41, 3448–3451. [Google Scholar]
  • (11).Bunnett JF; Zahler RE Aromatic Nucleophilic Substitution Reactions. Chem. Rev 1951, 49, 273–412. [Google Scholar]
  • (12).Bartoli G; Todesco PE Nucleophilic Substitution. Linear Free Energy Relations between Reactivity and Physical Properties of Leaving Groups and Substrates. Acc. Chem. Res 1977, 10, 125–132. [Google Scholar]
  • (13).Wolfe JM; Fadzen CM; Holden RL; Yao M; Hanson GJ; Pentelute BL Perfluoroaryl Bicyclic Cell-Penetrating Peptides for Delivery of Antisense Oligonucleotides. Angew. Chem., Int. Ed 2018, 57, 4756–4759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (14).Price NC; Cohn M; Schirmer RH Fluorescent and Spin Label Probes of the Environments of the Sulfhydryl Groups of Porcine Muscle Adenylate Kinase. J. Biol. Chem 1975, 250, 644–652. [PubMed] [Google Scholar]
  • (15).Tucker MJ; Courter JR; Chen J; Atasoylu O; Smith AB III; Hochstrasser RM Tetrazine Phototriggers: Probes for Peptide Dynamics. Angew. Chem., Int. Ed 2010, 49, 3612–3616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (16).Zhang D; Devarie-Baez NO; Li Q; Lancaster JR; Xian M Methylsulfonyl Benzothiazole (MSBT): A Selective Protein Thiol Blocking Reagent. Org. Lett 2012, 14, 3396–3399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (17).Banerjee R; Pace NJ; Brown DR; Weerapana E 1,3,5-Triazine as a Modular Scaffold for Covalent Inhibitors with Streamlined Target Identification. J. Am. Chem. Soc 2013, 135, 2497–2500. [DOI] [PubMed] [Google Scholar]
  • (18).Shannon DA; Banerjee R; Webster ER; Bak DW; Wang C; Weerapana E Investigating the Proteome Reactivity and Selectivity of Aryl Halides. J. Am. Chem. Soc 2014, 136, 3330–3333. [DOI] [PubMed] [Google Scholar]
  • (19).Uneyama K Organofluorine Chemistry, 1st ed.; Wiley-Blackwell, 2006; p 352. [Google Scholar]
  • (20).Fadzen CM; Wolfe JM; Cho C-F; Chiocca EA; Lawler SE; Pentelute BL Perfluoroarene–Based Peptide Macrocycles To Enhance Penetration across the Blood–Brain Barrier. J. Am. Chem. Soc 2017, 139, 15628–15631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (21).Garlick JM; Mapp AK Selective Modulation of Dynamic Protein Complexes. Cell Chem. Biol 2020, 27, 986–997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (22).Matos MJ; Navo CD; Hakala T; Ferhati X; Guerreiro A; Hartmann D; Bernardim B; Saar KL; Companñón I; Corzana F; et al. Quaternization of Vinyl/Alkynyl Pyridine Enables Ultrafast Cysteine-Selective Protein Modification and Charge Modulation. Angew. Chem., Int. Ed 2019, 58, 6640–6644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (23).Tang K-C; Cao J; Boatner LM; Li L; Farhi J; Houk KN; Spangle J; Backus KM; Raj M Tunable Amine-Reactive Electrophiles for Selective Profiling of Lysine. Angew. Chem., Int. Ed 2022, 61, No. e202112107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (24).Tang KC; Maddox SM; Backus KM; Raj M Tunable Heteroaromatic Azoline Thioethers (HATs) for Cysteine Profiling. Chem. Sci 2022, 13, 763–774. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (25).Hansch C; Leo A Substituent Constants for Correlation Analysis in Chemistry and Biology; John Wiley & Sons, Inc., 1979. [DOI] [PubMed] [Google Scholar]
  • (26).O’Hagan D Polar Organofluorine Substituents: Multivicinal Fluorines on Alkyl Chains and Alicyclic Rings. Chem. - Eur. J 2020, 26, 7981–7997. [DOI] [PubMed] [Google Scholar]
  • (27).Blanch JH Determination of the Hammett Substituent Constants for the 2-, 3-, and 4-Pyridyl and -Pyridinium Groups. J. Chem. Soc. B 1966, 937–939. [Google Scholar]
  • (28).Anslyn EV; Dougherty DA Modern Physical Organic Chemistry; University Science Books, 2006. [Google Scholar]
  • (29).Reed AE; Curtiss LA; Weinhold F Intermolecular Interactions from a Natural Bond Orbital, Donor-Acceptor Viewpoint. Chem. Rev 1988, 88, 899–926. [Google Scholar]
  • (30).Barlin GB; Benbow JA Kinetics of Reactions in Heterocycles. Part X. Reactions of Substituted N-Methylpyridinium Salts with Hydroxide Ions. J. Chem. Soc., Perkin Trans 2 1974, 790–797. [Google Scholar]
  • (31).Mayr H; Ofial AR A Quantitative Approach to Polar Organic Reactivity. SAR QSAR Environ. Res 2015, 26, 619–646. [DOI] [PubMed] [Google Scholar]
  • (32).Mayr H; Ofial AR Do General Nucleophilicity Scales Exist? J. Phys. Org. Chem 2008, 21, 584–595. [Google Scholar]
  • (33).Brotzel F; Mayr H Nucleophilicities of Amino Acids and Peptides. Org. Biomol. Chem 2007, 5, 3814–3820. [DOI] [PubMed] [Google Scholar]
  • (34).Mayer RJ; Ofial AR Nucleophilicity of Glutathione: A Link to Michael Acceptor Reactivities. Angew. Chem., Int. Ed 2019, 58, 17704–17708. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (35).Saito F; Noda H; Bode JW Critical Evaluation and Rate Constants of Chemoselective Ligation Reactions for Stoichiometric Conjugations in Water. ACS Chem. Biol 2015, 10, 1026–1033. [DOI] [PubMed] [Google Scholar]
  • (36).Kalia J; Ronald TR Advances in Bioconjugation. Curr. Org. Chem 2010, 14, 138–147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (37).O’Hagan D Understanding Organofluorine Chemistry. An Introduction to the C-F Bond. Chem. Soc. Rev 2008, 37, 308–319. [DOI] [PubMed] [Google Scholar]
  • (38).Bowler JT; Wong FM; Gronert S; Keeffe JR; Wu W Reactivity in the Nucleophilic Aromatic Substitution Reactions of Pyridinium Ions. Org. Biomol. Chem 2014, 12, 6175–6180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • (39).Danehy JP; Parameswaran KN Acidic Dissociation Constants of Thiols. J. Chem. Eng. Data 1968, 13, 386–389. [Google Scholar]
  • (40).Mukaiyama T New Synthetic Reactions Based on the Onium Salts of Aza-Arenes [New synthetic methods (29)]. Angew. Chem., Int. Ed 1979, 18, 707–721. [Google Scholar]
  • (41).Lemek T; Mąkosza M; Stephenson DS; Mayr H Direct Observation of the Intermediate in Vicarious Nucleophilic Substitutions of Hydrogen. Angew. Chem., Int. Ed 2003, 42, 2793–2795. [DOI] [PubMed] [Google Scholar]
  • (42).Mąkosza M; Wojciechowski K Nucleophilic Substitution of Hydrogen in Heterocyclic Chemistry. Chem. Rev 2004, 104, 2631–2666. [DOI] [PubMed] [Google Scholar]
  • (43).Mąkosza M Nucleophilic Substitution of Hydrogen in Electron-Deficient Arenes, a General Process of Great Practical Value. Chem. Soc. Rev 2010, 39, 2855–2868. [DOI] [PubMed] [Google Scholar]
  • (44).Mayer RJ; Breugst M; Hampel N; Ofial AR; Mayr H Ambident Reactivity of Phenolate Anions Revisited: A Quantitative Approach to Phenolate Reactivities. J. Org. Chem 2019, 84, 8837–8858. [DOI] [PubMed] [Google Scholar]
  • (45).Meerwein H; Hinz G; Hofmann P; Kroning E; Pfeil E Über Tertiäre Oxoniumsalze, I. J. Prakt. Chem. A 1937, 147, 257–285. [Google Scholar]
  • (46).Meerwein H; Battenberg E; Gold H Über Tertiäre Oxoniumsalze, II. J. Prakt. Chem. B 1939, 154, 83–156. [Google Scholar]
  • (47).Meldal M; Tornøe CW Cu-Catalyzed Azide–Alkyne Cycloaddition. Chem. Rev 2008, 108, 2952–3015. [DOI] [PubMed] [Google Scholar]
  • (48).Rostovtsev VV; Green LG; Fokin VV; Sharpless KB A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal Alkynes. Angew. Chem., Int. Ed 2002, 41, 2596–2599. [DOI] [PubMed] [Google Scholar]
  • (49).Wang Q; Chan TR; Hilgraf R; Fokin VV; Sharpless KB; Finn MG Bioconjugation by Copper(I)-Catalyzed Azide-Alkyne [3 + 2] Cycloaddition. J. Am. Chem. Soc 2003, 125, 3192–3193. [DOI] [PubMed] [Google Scholar]
  • (50).Huisgen R Kinetics and Mechanism of 1,3-Dipolar Cycloadditions. Angew. Chem., Int. Ed 1963, 2, 633–645. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supporting Information

RESOURCES